Vaccines

The Advisory Committee on Immunization Practices has released its updates to the annual immunization schedules for 2023 that includes new sections on COVID-19 and polio vaccine recommendations.

This COVID-19 roundup includes coverage on a revised version of the FDA’s emergency use authorization of tixagevimab/cilgavimab, a new study that compared the efficacy of vaccines and boosters in mortality...

This COVID-19 roundup includes coverage on vaccine safety for older adults, the efficacy of fluvoxamine on COVID-19 symptoms, the use of convalescent plasma transfusion in immunocompromised patients, and...

This COVID-19 roundup includes coverage on vaccine safety for pediatric patients with MIS-C, molnupiravir not reducing hospital admissions or deaths, the evolution of COVID-19 standard of care measures and...

This COVID-19 roundup includes coverage of the FDA’s modification of bivalent vaccines in infants aged 6 months, the NIH advises against the use of bebtelovimab, and impact COVID-19 has on short-term...

This COVID-19 roundup includes coverage of the FDA’s recent approval of bivalent booster vaccines for younger age groups, the use of COVID-19 PrEP and associated risk for the virus, an increase of...

The US Food and Drug Administration (FDA) approved the use of JYNNEOS vaccine for individuals who are at high risk of monkeypox infection.

The researchers sought to better understand the public health impact of immunization in children aged 10 years or younger in the United States.

Researchers examined the relationship between influenza vaccination and the development of Alzheimer disease in older US adults.

The US Food and Drug Administration has approved a new option for immunization against measles, mumps, and rubella.